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Degenerative aortic stenosis remains as‑
ymptomatic for a few years, but it eventually 
leads to symptom occurrence resulting from 
the high resistance of the aortic valve, elevated 
left ventricular end ‑diastolic pressure, and in‑
creasing pressure in pulmonary capillaries. In‑
creasing systemic vascular resistance and stiff‑
ness may also contribute to the vicious circle of 
DAS.6 Once symptoms of DAS develop, life ex‑
pectancy is shortened to around 3 years, unless 
IntroductIon The incidence of degener‑
ative aortic stenosis (DAS) increases with age, 
and the coincidence of advanced age, severe DAS, 
and cardiovascular comorbidities such as hyper‑
tension, atherosclerosis, arrhythmia, or diabe‑
tes is a common observation.1‑4 Degenerative 
aortic stenosis is not only a valvular disease, as 
it also leads to extravalvular cardiac complica‑
tions such as left ventricular hypertrophy, re‑



















Background Degenerative aortic stenosis (DAS) and cognitive function deterioration frequently coexist 
in elderly patients, which affects the prognosis.
aims We aimed to evaluate the Willis circle intracranial blood flow parameters and cognitive status in 
patients with DAS.
methods Ultrasonography of the Willis circle and the assessment of cerebral blood flow (CBF) volume, 
acceleration time (AT), pulsatile and resistive indexes (PI, RI), as well as cognition tests (Mini ‑Mental 
State Examination [MMSE] and Montreal Cognitive Assessment [MoCA]) were performed in group 1—41 
patients with severe DAS (aortic valve area indexed to the body surface area [AVAi] <0.5 cm2/m2) and 
group 2—41 patients with moderate DAS (AVAi [range], 0.51–0.99 cm2/m2). The control group comprised 
52 patients without DAS.
results Compared with controls, mean (SD) CBF volume in groups 1 and 2 was lower (1.37 [0.32] l/min vs 
1.5 [0.44] l/min vs 1.71 [0.21] l/min, respectively; P <0.001), while AT (212 [20] ms vs 161 [33] ms vs 86 [21] ms, 
respectively; P <0.001), RI (0.64 [0.07] vs 0.65 [0.06] vs 0.59 [0.05], respectively; P <0.001), and PI (1.13 [0.21] 
vs 1.16 [0.17] vs 0.99 [0.12]; P <0.001) were higher. Both MMSE and MoCA scores did not differ according to 
CBF, RI, PI, and AT. In multivariable regression analysis, age, renal failure, left ventricular ejection fraction, 
and diabetes, yet not CBF parameters, were independently associated with cognitive function.
conclusions Patients with DAS had significantly reduced CBF volume and increased arterial stiffness. 
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acute heart failure (n = 5), left ventricular ejec‑
tion fraction (LVEF) <40% (n = 7), aortic dissec‑
tion (n = 1), neurodegenerative disease or diag‑
nosed Alzheimer dementia (n = 2), and lack of 
the signed informed consent form (n = 1).
Eventually, a study cohort included 82 patients 
with DAS: group 1—41 patients with severe DAS 
(AVAi <0.5 cm2/m2) and group 2—41 patients 
with moderate DAS (AVAi [range], 0.51–0.99 cm2/
m2). The control group comprised 52 patients 
with a normal aortic valve.
All study patients underwent clinical evalua‑
tion including the New York Heart Association 
classification and the Canadian Cardiovascular 
Society grading system for exertion ‑induced an‑
gina, body mass index, and the assessment of 
major cardiovascular risk factors (sex, age, hy‑
pertension, diabetes, hyperlipidemia, and smok‑
ing status) and comorbidities (eg, chronic renal 
failure). All patients with a history of syncope 
had head computed tomography or magnetic 
resonance imaging performed, as recommend‑
ed by the consulting neurologist.
In all study patients, an adequate acous‑
tic temporal window was obtained, which al‑
lowed us to assess the WC cerebral arteries us‑
ing transcranial color ‑coded Doppler (TCCD) 
ultrasonography. Patients’ cognitive status 
was assessed with the Mini ‑Mental State Ex‑
amination (MMSE) and the Montreal Cogni‑
tive Assessment (MoCA) tests. Transthorac‑
ic echocardiography, carotid and vertebral ar‑
tery ultrasonography, TCCD ultrasonography 
of the WC, along with cognitive status tests 
were also carried out.
The study protocol complied with the Dec‑
laration of Helsinki and was approved by 
the  local institutional ethics committee 
(1072.6120.148.2018). All patients provided in‑
formed consent to participate in the study.
echocardiographic examination All patients 
underwent a complete echocardiographic exam‑
ination in line with the guidelines of the Euro‑
pean Association of Cardiovascular Imaging.12 
The peak and mean gradients through the aor‑
tic valve, AVA, AVAi, and LVEF were assessed in 
the entire study cohort.
carotid and vertebral artery ultrasonography 
High ‑resolution B ‑mode, color Doppler, and 
pulsed Doppler ultrasonography of both carot‑
id and vertebral arteries were performed us‑
ing an ultrasound machine (Aplio 450, Toshi‑
ba, Canon Medical Systems GmbH, Neuss, Ger‑
many) equipped with a 5–10‑MHz linear ‑array 
transducer in a patient in supine position with 
the head tilted slightly backward. The exami‑
nation was conducted by experienced sonogra‑
phers who had no prior knowledge of the indi‑
vidual’s clinical, echocardiographic, and angio‑
graphic characteristics.
the mechanical obstruction to left ventricular 
outflow is relieved by aortic valve replacement.7‑10
The symptoms of DAS (angina, dyspnea, and 
syncope) often overlap with those of other com‑
mon diseases such as ischemic heart disease, 
anemia, hypertension, or cerebral ischemia.11‑14 
While cardiac output becomes gradually reduced, 
cerebral and peripheral flow volume also puta‑
tively decrease, resulting in syncope or cere‑
bral hypoperfusion. It remains unclear whether 
the reduced cerebral blood flow (CBF) may cause 
cognitive decline in patients with DAS.15,16 Fur‑
thermore, identifying a hemodynamic thresh‑
old for cognitive decline using a simple, nonin‑
vasive method may influence decision ‑making 
in otherwise “asymptomatic” DAS.10
The potential relationship between the arte‑
rial flow changes in the Willis circle (WC) and 
cognitive function status in patients with symp‑
tomatic DAS has not been studied yet. Therefore, 
the present study aimed to assess the CBF pa‑
rameters of the WC and the cognitive status of 
patients with moderate ‑to ‑severe DAS as well 
as to determine which parameters may be as‑
sociated with cognitive decline.
Methods We initially screened 139 individu‑
als with DAS  who were referred for elective cor‑
onary angiography and in whom aortic valve in‑
tervention was considered. Patients were divid‑
ed into groups based on the echocardiograph‑
ic aortic valve area indexed to the body surface 
area (AVAi).
Out of 139 patients with DAS, 57 were ex‑
cluded from the study owing to ultrasonograph‑
ic or clinical conditions that could bias data in‑
terpretation, including a significant stenosis 
of any carotid or vertebral artery (exceeding 
50% lumen reduction [n = 5]), suboptimal acous‑
tic temporal window (n = 7), permanent atri‑
al fibrillation or other severe rhythm distur‑
bances (n = 6), significant concomitant valvular 
diseases (n = 14), recent myocardial infarction 
(<3 months) (n = 3), ischemic stroke or transient 
ischemic attack (n = 6), hemodynamic insta‑
bility: New York Heart Association class IV or 
whAt’s new?
In the rapidly aging population, degenerative aortic stenosis (DAS) as well as 
cognitive function impairment frequently coexist in elderly patients and affect 
their prognosis. Whether cognitive decline is due to decreased cardiac output 
and altered cerebral blood flow in response to DAS or results from atherosclerosis 
risk factors remains unclear. The present study addresses this issue through 
the analysis of cerebral blood flow volume, cerebral arterial stiffness, and 
cardiovascular comorbidities in patients with an aortic valve area indexed to 
the body surface area less than 0.99 cm2/m2. Our findings indicate that: 1) patients 
with DAS have a significantly decreased cerebral blood flow volume and increased 
arterial stiffness; and 2) cognitive impairment is attributed to comorbidities 
rather than cerebral blood flow parameters in this subset of patients.
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Univariable and multivariable regression anal‑
yses were performed for the MMSE and MoCA 
tests to identify independent clinical parame‑
ters associated with cognitive status. Multivari‑
able logistic regression analysis was carried out 
for variables significant in univariate analyses 
at P <0.1. The results were expressed as odds ra‑
tios (ORs) and 95% CIs.
The Statistica 13.0 software (StatSoft Polska, 
Kraków, Poland) was used for statistical anal‑
ysis. A P value less than 0.05 was considered 
significant.
results Patients in groups 1 and 2 were sim‑
ilar with respect to age, sex, and all major ath‑
erosclerosis risk factors, except previous cardiac 
interventions (TAbLE 1). Control subjects more fre‑
quently had hypertension, hyperlipidemia, and 
a history of coronary artery disease and coro‑
nary interventions (TAbLE 1).
Groups 1 and 2 had lower mean (SD) 
CBF than controls (1.37 [0.32]  l/min vs 
1.5 [0.44] l/min vs 1.71 [0.21] l/min; P <0.001). 
Compared with controls, the mean (SD) val‑
ues of AT (212 [20] ms vs 161 [33] ms vs 86 
[21] ms; P <0.001), RI (0.64 [0.07] vs 0.65 [0.06] 
vs 0.59 [0.05]; P <0.001), and PI (1.13 [0.21] vs 
1.16 [0.17] vs 0.99 [0.12]; P <0.001) were high‑
er in groups 1 and 2 (FIgUrE 1).
Both RI and PI were significantly correlated 
with mean (r = –0.331, P = 0.003 and r = –0.293, 
P = 0.009, respectively) and peak (r = –0.316, 
P = 0.005 and r = –0.265, P = 0.02, respective‑
ly) aortic gradients as well as AVAi (r = 0.296, 
P = 0.009 and r = 0.267, P = 0.02).
The mean (SD) MoCa and MMSE scores were 
similar in groups 1 and 2: 24.1 (3.8) vs 24.3 (4) 
points (P = 0.88) and 27.8 (2.9) vs 27.9 (2.6) 
points (P = 0.98), respectively.
Neither MoCA nor MMSE scores were pre‑
dictable by AT (r = 0.08, P = 0.49 and r = 0.15, 
P = 0.22), RI (r = –0.04, P =0.74 and r = 0.12, 
P = 0.32), PI (r = –0.04, P = 0.75 and r = 0.09, 
P = 0.43), or CBF (r = –0.054, P = 0.64 and 
r  =  0.08, P  =  0.49), respectively. Howev‑
er, the MoCA score was correlated with age 
(r = –0.242, P = 0.04). Both MoCA and MMSE 
scores were lower in patients with diabetes 
(P = 0.014 and P = 0.011, respectively), chronic 
renal failure (P = 0.022 and P = 0.065, respec‑
tively), and lower LVEF (P = 0.018 and P = 0.059, 
respectively).
In multivariable regression analysis, the MoCA 
score was associated with diabetes (OR, 1.29; 
95% CI, 1.09–1.52; P = 0.002), chronic renal fail‑
ure (OR, 1.24; 95% CI, 1.19–1.29; P = 0.05), age 
(OR, 1.23; 95% CI, 1.1–1.37; P = 0.036), and LVEF 
(OR, 1.16; 95% CI, 1.02–1.32; P = 0.002), while 
the MMSE score with diabetes (OR, 1.29; 95% CI, 
1.05–1.6; P = 0.021) and chronic renal failure (OR, 
1.32; 95% CI, 1.07–1.64; P = 0.012) (FIgUrE 2).
Ultrasonographic data comprised the bilateral 
recording of the peak systolic velocity (PSV) and 
the end ‑diastolic velocity (EDV), as well as a ves‑
sel diameter measured within the 1–1.5‑cm prox‑
imal segment of the internal carotid artery and 
the proximal V2 segment of the vertebral artery.
The  luminal diameter was determined on 
the enlarged B ‑mode image of the vessel and re‑
garded as the distance between the internal layers 
of the parallel walls. At the same site, a Doppler 
sample volume was positioned to cover the entire 
luminal width with an angle correction of 60 de‑
grees. Angle ‑corrected PSV, EDV, time ‑averaged 
velocity (TAV) of blood flow, and mean TAV were 
averaged from 3 complete cardiac cycles.
The  total CBF volume was determined as 
the sum of the individual flow volumes calculat‑
ed for both internal carotid and vertebral arteries. 
Flow volume was calculated as the product of mean 
TAV and the vessel diameter according to the fol‑
lowing equation: CBF = TAV × (π × [d/2]²), where 
CBF is cerebral flow volume, TAV is the time‑
‑averaged blood flow velocity estimated by the ul‑
trasound system, and d is the vessel diameter.
Transcranial color ‑coded Doppler ultrasonography 
The TCCD ultrasonography examination of the in‑
tracranial arteries was performed in all patients 
in supine position, through the temporal win‑
dow, using the Toshiba Aplio machine equipped 
with a 1.6–2‑MHz sector ‑array transducer. Both 
PSV and EDV in the WC proximal segments of 
the middle, anterior, and posterior cerebral ar‑
teries were recorded on admission, and the accel‑
eration time (AT), pulsatile index (PI), and resis‑
tive index (RI) were calculated in each evaluated 
segment from the following equations:
RI = PSV – EDV / PSV
PI = PSV – EDV / ([PSV + 2 × EDV] / 3)
Acceleration time was defined as the time 
from the minimum EDV to PSV. The averaged 
values of AT, RI, and PI from all cerebral arter‑
ies were subjected to further statistical analysis.
cognitive status assessment Before coro‑
nary angiography, the cognitive function of the 
study participants was assessed with the MoCA17 
and MMSE18 scales by a neuropsychologist who 
was blinded to clinical data. The exclusion cri‑
teria were the cutoff score values equal to or be‑
low 20 and 14 for MMSE and MoCA, respective‑
ly, which suggested severe dementia.
statistical analysis Continuous variables 
were presented as mean (SD), and categorical 
variables, as number (percentage). Differences 
between the analyzed parameters were tested by 
the Mann–Whitney test. The Spearman correla‑
tion coefficient was calculated for CBF parame‑
ters and cognitive function scores. The normal 
distribution of the variables was determined by 
the Shapiro–Wilk test.
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arterial stiffness. Moreover, PI and RI were sig‑
nificantly correlated with AVAi.
Increased arterial stiffness is a strong indica‑
tor of the increased risk of mortality and cardio‑
vascular events.19‑21 In diabetic patients, PI may 
predict cerebrovascular complications, while in 
dIscussIon Our study demonstrated that 
patients with DAS had reduced CBF compared 
with patients with normal aortic valves. Fur‑
thermore, we found higher values of PI and RI 
in those with moderate ‑to ‑severe DAS compared 
with the control group, which indicated greater 
Table 1 Clinical characteristics of the study population
Variable Group 1a  
(n = 41)










and 2 vs 
controls)
Demographic data
Age, y, mean (SD) 68.2 (7.6) 70.5 (7.7) 0.15 67.7 (8.7) 0.25
Female sex 20 (48.7) 24 (58.5) 0.38 27 (51.9) 0.17
Clinical symptoms
NYHA class I 7 (17.1) 23 (56.1) <0.001 38 (73.1) <0.001
NYHA class II / III 34 (82.9) 18 (43.9) <0.001 14 (26.9) <0.001
CCS ≥II 4 (9.7) 12 (29.2) 0.03 27 (51.9) <0.001
Syncope 2 (4.9) 3 (7.3) 0.64 1 (1.9) 0.26
Comorbidities
Hypertension 38 (92.6) 39 (95.1) 0.64 40 (76.9) 0.004
Diabetes 12 (29.3) 15 (36.6) 0.48 17 (32.7) 0.98
Dyslipidemia 40 (97.6) 37 (90.2) 0.12 43 (82.7) 0.039
Smoking status 23 (58.7) 17 (40) 0.19 24 (46.2) 0.77
BSA, m2, mean (SD) 1.91 (0.19) 1.91 (0.2) 0.64 1.89 (0.19) 0.46
BMI, kg/m2, mean (SD) 30.8 (5.4) 30.6 (5.3) 0.55 28.9 (5.2) 0.13
Coronary artery diseasec 12 (29.3) 10 (24.4) 0.62 32 (61.5) 0.0001
Previous myocardial infarction 2 (4.9) 7 (17.1) 0.08 22 (42.3) <0.001
Previous cardiac interventions 5 (12.1) 17 (41.5) 0.003 26 (50) 0.006
Renal failure (eGFR <60 ml/min/1.73 m2) 5 (12.2) 8 (19.5) 0.36 10 (19.2) 0.61
Laboratory test results, mean (SD)
Creatinine, µmol/l 80.8 (15.2) 79.7 (22.4) 0.3 89.4 (21.3) 0.12
eGFR, ml/min/1.73 m2 76.7 (15.2) 76 (17.7) 0.84 74.7 (18.2) 0.79
LDL cholesterol, mmol/l 2.8 (1) 2.7 (0.9) 0.82 2.92 (1) 0.26
Selected echocardiographic data, mean (SD)
LVEF, % 63 (7) 61 (8) 0.28 62 (8) 0.85
Mean aortic gradient, mm Hg 60.5 (18.6) 30 (11.3) <0.001 NA NA
Peak aortic gradient, mm Hg 98.4 (30.6) 50 (17.9) <0.001 NA NA
Peak aortic valve velocity, m/s 4.86 (0.7) 3.43 (0.65) <0.001 NA NA
AVA, cm2 0.78 (0.15) 1.27 (0.28) <0.001 NA NA
AVAi, cm2 0.4 (0.07) 0.67 (0.14) <0.001 NA NA
Data are presented as number (percentage) unless otherwise indicated.
a AVAi ≤0.5 cm2/m2
b AVAi, 0.51–0.99 cm2/m2
c Coronary artery disease with lumen stenosis >50% in at least one coronary artery
Abbreviations: AVA, aortic valve area; AVAi, aortic valve area indexed to the body surface area; BMI, body mass index; BSA, body surface 
area; CCS, Canadian Cardiac Society; eGFR, estimated glomerular filtration rate; LVEF, left ventricular ejection fraction; NA, not applicable
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the PI values in symptomatic patients typical‑
ly documented as lower than 1.24,25 Heyer et al25 
found that patients with symptomatic carot‑
id artery stenosis who had a baseline PI below 
0.8 were likely to have increased CBF and im‑
proved cognitive function after carotid endar‑
terectomy.25 Thus, decreased PI would be asso‑
ciated with improved prognosis.
These unexpectedly high values of RI and PI 
in patients with DAS, which obviously indicate 
the failure of the physiological autoregulation 
mechanism in response to reduced CBF, can be 
partially explained by the negative impact of 
age and comorbidities, such as diabetes, hyper‑
lipidemia, and hypertension, resulting in the in‑
creased stiffness of the macrovasculature and 
small ‑vessel disease.26‑29
Another common belief is that CBF or CBF 
velocity should be correlated with cognitive 
hypertensive individuals, it reflects the chronic‑
ity of the disease.19‑21
Similar to our study, Cay et al22 demonstrated 
higher aortic PI in patients with DAS compared 
with the control group. Moreover, as in our study, 
PI was significantly correlated with aortic gradi‑
ents, which confirms the association between ar‑
terial stiffness and the severity of calcific DAS.22 
However, it remains unclear whether calcific DAS 
leads to increased arterial stiffness or increased 
arterial stiffness leads to the gradual development 
of DAS. Most probably, both mechanisms coexist.
Our finding of increased arterial stiffness is 
in contrast to what we would expect, because, 
putatively, DAS leading to the hypoperfusion of 
the brain structures should be associated with 
decreased cerebral RI and PI.23 Reduced cerebral 
vascular resistance, likely through autoregula‑
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in this patient population, cognitive impairment 
may be attributed to concomitant diseases rath‑
er than cerebral flow parameters.
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status.30‑32 However, previous reports have only 
partially explained the relationship between cog‑
nition and hemodynamics.31,32 In a study by Kid‑
her et al,15 which included 56 patients with severe 
DAS, aortic stiffness ( assessed by carotid–femoral 
pulse wave velocity) was an indicator of preopera‑
tive cognitive dysfunction.12 These data were sup‑
ported by the results of an observational study 
of 42 patients with high ‑grade, asymptomatic ca‑
rotid artery stenosis, in whom cognitive impair‑
ment was linearly correlated with mean flow ve‑
locity below a threshold of 45 cm/s in the hemi‑
sphere supplied by the stenosed internal carotid 
artery.30 In line with this finding, carotid artery 
stenosis may be associated with mild cognitive 
impairment in either neurologically symptomatic 
or asymptomatic patients.26,33 In a group of 60 pa‑
tients with ulcerated plaque causing internal ca‑
rotid artery stenosis ≥70%, Puz et al34 showed re‑
duced cerebrovascular reactivity, which indicated 
a crucial role of TCCD ultrasonography.
However, most cohort studies have not elu‑
cidated whether cognitive status is attributable 
to decreased CBF due to DAS or carotid steno‑
sis or there are other coplayers that impact cog‑
nitive decline.
In the present study, we did not show a direct 
relationship between CBF or arterial stiffness 
parameters and the results of cognitive tests. 
Other variables such as age, diabetes, chronic 
renal failure, and left ventricular systolic func‑
tion represented the independent determinants 
of cognitive status. This is in line with data from 
other observational studies.35‑39 Diabetes was 
a relevant predictor of cognitive decline in the el‑
derly, associated with deficits in attention and 
executive functions in some studies, whereas 
the greater the severity of chronic kidney dis‑
ease, the greater the progression of cognitive 
decline was observed.35‑38 At present, the main 
treatment strategy in vascular cognitive impair‑
ment is prevention by treating vascular diseas‑
es and controlling other risk factors such as hy‑
pertension and diabetes.40
study limitations Admittedly, our study in‑
cluded relatively small groups of patients with 
DAS, which was due to numerous ultrasono‑
graphic and clinical exclusion criteria that could 
potentially bias the interpretation of results. 
The control group was not matched by the prev‑
alence of risk factors; for that reason, no cog‑
nitive tests from that group were subjected to 
statistical analysis. Apart from patients with a 
history of syncope, none of the study partici‑
pants underwent a routine neurological exami‑
nation or neuroimaging. Diseases of the central 
nervous system could also influence the results.
conclusions Our findings showed that pa‑
tients with DAS have significantly decreased 
CBF and increased arterial stiffness. However, 
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